RV fibrosis in pulmonary hypertension impact on prognosis; does formal quantitation augment prognosis?
Siva Soma(Allegheny General Hospital), Robert W Biederman(Allegheny Health Network), Raymond L. Benza(Triangle), Vishal Goyal(Chandigarh University), Mark Doyle(Allegheny General Hospital), June Yamrozik(Allegheny General Hospital), Srinivas Murali(Allegheny General Hospital), Ronald B Williams(Allegheny General Hospital)
Cited by 0
Related Papers
Predicting Survival in Pulmonary Arterial Hypertension
|Circulation|2010|1.5k
Clinical risk factors for portopulmonary hypertension†
|Hepatology|2008|286
Genetic Risk Factors for Portopulmonary Hypertension in Patients with Advanced Liver Disease
|American Journal of Respiratory and Critical Care Medicine|2009|232
Recent Development of Visceral Leishmaniasis Treatments: Successes, Pitfalls, and Perspectives
|Clinical Microbiology Reviews|2018|218
Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis
|The Lancet Respiratory Medicine|2018|212